Effects of psychotropic drugs on seizure threshold

Drug Safety

Volumn 25, Issue 2, 2002, Pages 91-110

  Pisani, Francesco ^a,b   Oteri, Giancarla ^a   Costa, Cinzia ^a   Di Raimondo, Giorgio ^a   Di Perri, Raoul ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CHLORPROMAZINE; CLOMIPRAMINE; CLOZAPINE; FLUOXETINE; FLUPHENAZINE; HALOPERIDOL; MAPROTILINE; NEUROLEPTIC AGENT; PAROXETINE; PHENELZINE; PIMOZIDE; RISPERIDONE; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; VENLAFAXINE;

CLINICAL PRACTICE; DEPRESSION; DOSE CALCULATION; DOSE RESPONSE; DRUG MECHANISM; DRUG OVERDOSE; EPILEPTOGENESIS; HUMAN; INCIDENCE; MENTAL HEALTH; METHODOLOGY; NEUROMODULATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; RISK ASSESSMENT; SEIZURE; SEIZURE THRESHOLD;

EID: 0036193906     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200225020-00004     Document Type: Review

References (166)

1. Antidepressants and convulsive seizures: Clinical, electroencephalographic and pharmacological aspects
2. The organic contribution to depressive illness in patients with epilepsy
3. Suicide and epilepsy: A review of the literature
4. Preliminary observations on the psychiatric use of chlorpromazine
5. The treatment of depressive states with imipramine hydrochloride (Tofranil)
6. Treatment of severe depression by imipramine: An investigation of 100 cases
7. Convulsions associated with anti-depressant drugs
8. An electroencephalographic study on the analeptic effects of imipramine
9. EEG activation after intravenous amitriptyline
10. EEG activation with amitriptyline
11. Clinical note: Seizures and EEG activation after trimipramine
12. Unusual spike-wave stupor in a patient with manic-depressive psychosis treated with amitriptyline
13. Drags modifying dopaminergic activity and behaviour, the EEG and epilepsy in papio papio
14. The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967
15. Incidence of seizures during treatment with tricyclic antidepressant drugs and bupropion
16. Tricyclic antidepressant and convulsions
17. Seizures associated with antidepressants: A review
18. Maprotiline treatment in depression: A perspective on seizures
19. Prescription-event monitoring of 10401 patients treated with fluvoxamine
20. Spontaneous epileptic seizures and electroencephalographic changes in the course of phenothiazine therapy
21. Clozapine-related seizures
22. Clozapine-related seizures: Experience with 5,629 patients
23. Psychotropic drug-induced reductions in seizure threshold: Incidence and consequences
24. Seizure risk associated with psychotropic drugs: Clinical and pharmacokinetic considerations
25. Very high dosage versus standard dosage fluphenazine in schizophrenia
26. Effects of risperidone in overdose
27. Adverse drug reactions - 'Time-less' risks (a hazard of risk assessment: The example of seizure and antidepressants)
28. Antipsychotic medications and seizures
29. Post-marketing surveillance: How many patients?
30. Value of initial ECG findings and plasma drug levels in cyclic antidepressant overdose
31. Efficacy of Tofranil in the treatment of various types of depression: A comparison with other antidepressant drugs
32. Clinical effectiveness of Tofranil in the treatment of depressive psychoses
33. A brief note on the problem of epilepsy in antidepressant treatment
34. Incidence of seizures with tricyclic and tetracyclic antidepressants
35. Seizures during tricyclic therapy
36. Influence of lithium carbonate on patients with temporal epilepsy
37. Epileptic fits as a probable side-effect of amitriptyline: Report of seven cases
38. Iatrogenic epilepsy due to antidepressant drugs
39. Mianserin and convulsive seizures
40. Drug induced seizures: Controversies in their identification and management
41. The incidence of seizures during tricyclic antidepressant drug treatment in a brain-injured population
42. Clozapine response and adverse effects in nine brain-injured patients
43. Drug-induced seizures in the elderly: Causative agents and optimal management
44. Seizures and myoclonus associated with antidepressant treatment: Assessment of potential risk factors, including CYP2D6 and CYP2C19 polymorphisms, and treatment with CYP2D6 inhibitors
45. Epileptogenic side effects of psychotropic drugs
46. Antidepressants and seizures: Clinical anecdotes overshadow neuroscience
47. Which is the safest antidepressant to use in epilepsy?
48. Non-monoamine oxidase inhibitor antidepressants and epilepsy: A review
49. Poisoning with tricyclic and related antidepressant: A ten year review
50. Tricyclic antidepressant overdose: Incidence of symptoms
51. Seizures with promazine, preliminary report
52. Tricyclic antidepressant-induced seizures and plasma drug concentration
53. Partial status epilepticus following single low dose of chlorimipramine in a patient on MAO-inhibitor treatment
54. Myoclonus during combined tryciclic antidepressant and lithium treatment
55. Recurrence of absence seizures induced by a low dose of amitriptyline: A case report
56. Status epilepticus associated with the combination of valproic acid and clomipramine
57. Non-convulsive status epilepticus induced by antidepressants
58. Incidence and prognostic significance of 'epileptiform' activity in the EEG of non-epileptic subjects
59. EEG and psychotropic drugs
60. Mianserin, maprotiline and the electroencephalogram
61. Psychotropic drugs and the human EEG
62. Chlorpromazine versus sleep deprivation in activation of EEG in adult-onset partial epilepsy
63. Epileptic seizures induced by psychotropic drugs
64. Seizures with antidepressants: An in vitro technique to assess relative risk
65. Neuroleptic-induced seizures: An in vitro technique for assessing relative risk
66. EEG, drug effects, and central nervous system poisoning
67. EEG profiles and bioavailability measures of psychoactive drugs
68. Pharmaco-EEG: Computer EEG analysis to describe the projection of drug effects on a functional cerebral level in humans
69. Drug effects
70. EEG changes under lithium (Li) treatment
71. EEG and lithium CNS toxicity
72. Clozapine-induced seizures and EEG changes
73. Electroencephalographic findings with low-dose clozapine treatment in psychotic parkinsonian patients
74. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels
75. A comparison of the effects of clozapine and olanzapine on the EEG in patients with schizophrenia
76. Electroencephalogram alterations during treatment with olanzapine
77. Seizure activity associated with fluoxetine therapy
78. Seizure after isolated fluoxetine overdose
79. A seizure, and electroencephalographic signs of a lowered seizure threshold, associated with fluvoxamine treatment of obsessive-compulsive disorder
80. Citalopram overdose: Review of cases treated in Swedish hospitals
81. Maprotile hydrochloride associated with a clinical state of catatonic stupor and epileptic encephalogram
82. New antidepressant drugs and the seizure threshold
83. Seizures and trazodone therapy
84. The safety of antidepressants
85. Partial complex status epilepticus in a lithium-toxic patient
86. Antidepressants and the risk of seizures
87. Antipsychotic drugs and seizures
88. Seizures with neuroleptics and antidepressants
89. The psychoses of epilepsy and their treatment
90. The treatment of depression in patients with epilepsy: A double-blind trial
91. Epileptic and anti-epileptic properties of psychotropic drugs
92. Convulsive and anticonvulsive properties of neuropsychopharmaca
93. High dose chlorpromazine therapy in chronic schizophrenia
94. Tricyclic antidepressant overdose: A review
95. Amitriptyline and imipramine poisoning in children
96. Seizures associated with poisoning and drug overdose
97. Tricyclic-induced electroencephalogram abnormalities and plasma drug concentrations
98. Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants
99. Haloperidol dose and blood level variability: Toxicity and interindividual and intraindividual variability in the nonresponder patient in the clinical practice setting
100. Antidepressant drugs, convulsions, and epilepsy
101. Pharmacokinetic interaction between antiepileptic and psychotropic drugs
102. Newer and older antidepressants: A comparative review of drug interactions
103. Interactions between anticonvulsant and psychoactive drugs
104. Anticonvulsant co-treatment may increase toxic metabolites of antidepressants and other psychotropic drugs
105. Paradoxical intoxication: A complication of anticonvulsant administration
106. Carbamazepine-induced seizures
107. Toxic serotonin syndrome after fluoxetine plus carbamazepine
108. Toxic reaction following the combined administration of fluoxetine and phenytoin: Two case reports
109. Monotherapy or polytherapy for epilepsy?
110. Psychiatric disorders of epilepsy: Classification and phenomelogy
111. Neurobehavioral problems in epilepsy
112. Thioridazine hydrochloride in the treatment of behavior disorders in epileptics
113. Effect of doxepine on seizure frequency in depressed epileptic patients
114. Anticonvulsant drugs
115. Imipramine in epilepsy
116. A clinical and experimental investigation of the effect of imipramine on epilepsy
117. Imipramine in absence and myoclonic-astatic seizures
118. Clomipramine et petit mal
119. Reduction of seizure frequency with clomipramine in patients with complex partial seizures
120. Anticonvulsant effect of fluoxetine in humans
121. Biphasic effects of imipramine in experimental models of epilepsy
122. The pharmacology of antidepressant agents
123. Studies of drug effects on electrically induced extensor seizures and clinical implications
124. The effect of antidepressant drugs on the convulsive excitability of brain structures
125. Anticonvulsant and proconvulsant properties of viloxazine hydrochloride: Pharmacological and pharmacokinetic studies in rodents and the epileptic baboon
126. Anticonvulsant and proconvulsant doses of desipramine in the genetically epilepsy-prone rat
127. Anticonvulsant and proconvulsant effects of doxepin in genetically epilepsy prone rat (GEPR)
128. Effects of chronic treatment with haloperidol and methamphetamine on hippocampal kindled seizures in the cat
129. Protective effect of clozapine against pentylenetetrazol convulsions and kindling
130. Epileptic phenomena induced in the cat by the antidepressants maprotiline, imipramine, clomipramine and amitriptyline
131. Pro-convulsant anti-convulsant effects of tricyclic antidepressants in genetically epilepsy-prone rats
132. Landau-Kleffner syndrome: A pharmacologic study of five cases
133. Seizures induced or aggravated by anticonvulsants
134. Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children
135. Carbamazepine-induced seizures
136. Exacerbation of seizures in children by carbamazepine
137. Prolonged absence status epilepticus associated with carbamazepine therapy, increased intracranial pressure, and transient MRI abnormalities
138. Acute intoxication with valproate
139. Severe hepatotoxicity during valproate therapy: An update and report of eight new cases
140. Acute intoxication with sodium valproate
141. Tonic status epilepticus precipitated by intravenous benzodiazepine in five patients with Lennox-Gastaut syndrome
142. Tonic status epilepticus precipitated by intravenous diazepam in a child with petit mal status
143. Anticonvulsant-induced status epilepticus in Lennox-Gastaut syndrome
144. Paradoxical precipitation of tonic seizures by lorazepam in a child with atypical absence seizures
145. Epileptic seizures induced by clonazepam
146. Exacerbation of focal seizures due to carbamazepine treatment in an adult patient
147. Antiepileptic drugs as a cause of worsening seizures
148. Seizure activity in photosensitive baboons following antidepressant drugs and the role of serotonergic mechanisms
149. Biogenic amines and the photo-myoclonic syndrome in the baboon, papio papio
150. Serotonin metabolism in human epilepsy: The influence of anticonvulsant drugs
151. On the sacred disease: The neurochemistry of epilepsy
152. Serotonin reuptake inhibitors, epilepsy and myoclonus
153. Role of serotonin receptor subtype in seizures kindled from the feline hippocampus
154. Carbamazepine-induced release of serotonin from rat hippocampus in vitro
155. Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR)
156. GABA and mood disorders: A brief review and hypothesis
157. Anticonvulsant and antidepressant properties of electroconvulsive therapy: A proposed mechanism of action
158. Electroconvulsive therapy as an anticonvulsant: Implications for its mechanism of action in affective illness
159. Seizure threshold in electroconvulsive therapy (ECT) II: The anticonvulsant effect of ECT
160. Fluvoxamine: An antidepressant with low (or no) epileptogenic effect
161. The pharmacological management of epilepsy associated with psychological disorders
162. Clozapine and seizures: A review
163. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder